This announcement is a separate document:
藥明巨諾-B：自願公告 - 業務更新在第63屆美國血液學會年會上公佈倍諾達（瑞基奧侖賽注射液）的主要臨床效果
JW Therapeutics Co.Ltd: VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE PRIMARY CLINICAL RESPONSE ON Carteyva (RELMACABTAGENE AUTOLEUCEL INJECTION) AT THE 63RD AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING
Dec 13, 2021 08:04
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.